Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study for Patients With HIV and Confirmed SARS-CoV-2

NCT04333953 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT04333953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study for Patients With HIV and Confirmed SARS-CoV-2
Lead sponsor
University of Missouri-Columbia
Phase
Observational
Overall status
Completed
Start date
April 1, 2020
Completion date
March 28, 2022
Enrollment
412 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, hiv/aids, sars-cov-2